Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CLDI
CLDI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CLDI News
CALIDI BIOTHERAPEUTICS INC REPORTS Q4 NET LOSS OF $0.57 PER SHARE
3d ago
moomoo
Calidi Biotherapeutics Accelerates CLD-401 Clinical Trial Initiation
3d ago
Newsfilter
Calidi Biotherapeutics Reports FY Loss and Public Offering
3d ago
seekingalpha
Calidi Partners with Avance for First-in-Human Trial of CLD-401
6d ago
NASDAQ.COM
CALIDI Biotherapeutics Forms Partnership with Avance Clinical to Streamline Australian Regulatory Approval and Expedite CLD-401 Clinical Trials Launch
6d ago
moomoo
Calidi Biotherapeutics Completes $6 Million Public Offering
Mar 10 2026
Newsfilter
Calidi Biotherapeutics Prices Public Offering at $0.50 per Unit
Mar 09 2026
NASDAQ.COM
U.S. Stocks Decline Amid Weak Retail Sales Data
Mar 06 2026
Benzinga
Calidi Biotherapeutics Prices Public Offering of 10.52M Units
Mar 06 2026
seekingalpha
U.S. Stocks Decline as Unemployment Rate Rises
Mar 06 2026
Benzinga
Calidi Biotherapeutics Prices Public Offering of 10.5 Million Units
Mar 06 2026
Newsfilter
Calidi Biotherapeutics Shares Plunge 35.04% After Public Offering Announcement
Mar 06 2026
Benzinga
Calidi Biotherapeutics Announces Public Offering, Shares Plunge 31%
Mar 06 2026
NASDAQ.COM
Calidi Biotherapeutics Plans Public Offering of Stock Units
Mar 05 2026
Newsfilter
Calidi Biotherapeutics Announces Public Offering of Units
Mar 05 2026
seekingalpha
Calidi Biotherapeutics Unveils Novel Therapy Data at AACR-IO
Feb 20 2026
Yahoo Finance
Show More News